Want to join the conversation?
New Jersey-based company $ZTS said 2Q16 operational revenue was up 6%, excluding the impact of FX. Companion animal products grew 15% and livestock products grew 5%. The growth in companion animal products was based on strong performance by APOQUEL as well as the recently launched vaccines and SIMPARICA.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.